Back to top
more

Quidel Corporation (QDEL)

(Real Time Quote from BATS)

$120.19 USD

120.19
150,154

+0.68 (0.57%)

Updated Apr 21, 2021 11:21 AM ET

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.41%
2Buy19.02%
3Hold10.72%
4Sell6.46%
5Strong Sell3.06%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 15% (217 out of 254)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Zacks News

Quidel (QDEL) Stock Moves -0.28%: What You Should Know

Quidel (QDEL) closed at $129.24 in the latest trading session, marking a -0.28% move from the prior day.

Quidel (QDEL) Stock Sinks As Market Gains: What You Should Know

Quidel (QDEL) closed the most recent trading day at $128.33, moving -1.47% from the previous trading session.

Quidel (QDEL) Outpaces Stock Market Gains: What You Should Know

Quidel (QDEL) closed at $130.31 in the latest trading session, marking a +1.86% move from the prior day.

Quidel (QDEL) Gains But Lags Market: What You Should Know

In the latest trading session, Quidel (QDEL) closed at $126.30, marking a +0.13% move from the previous day.

Kevin Cook headshot

Bull of the Day: Meridian Bioscience (VIVO)

Delay in FDA approval for latest COVID test hasn't altered growth or value at 3X sales

Quidel (QDEL) Dips More Than Broader Markets: What You Should Know

Quidel (QDEL) closed the most recent trading day at $138.90, moving -1.53% from the previous trading session.

Quidel (QDEL) Q4 Earnings Top Estimates

Quidel (QDEL) delivered earnings and revenue surprises of 9.60% and -0.03%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Why Quidel Corp (QDEL) Might Surprise This Earnings Season

Quidel Corp (QDEL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Kevin Cook headshot

Bull of the Day: Meridian Bioscience (VIVO)

Small-cap diagnostics player will grow sales 30%+ to over $335 million on COVID-19 testing and its mutations

Quidel (QDEL) Gains As Market Dips: What You Should Know

Quidel (QDEL) closed the most recent trading day at $236.38, moving +1.5% from the previous trading session.

Why Quidel (QDEL) is Poised to Beat Earnings Estimates Again

Quidel (QDEL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Quidel (QDEL) to Report Q4 Earnings: What's in the Offing?

Quidel (QDEL) is likely to have witnessed a recovery in rapid immunoassay revenues during Q4.

Quidel (QDEL) Outpaces Stock Market Gains: What You Should Know

Quidel (QDEL) closed at $236.85 in the latest trading session, marking a +1.29% move from the prior day.

Urmimala Biswas headshot

3 MedTech Stocks Likely to Top Estimates This Earnings Season

Strong signs of rebound in base sales volumes make us optimistic about VIVO, XRAY, and PDCO's results.

Quidel (QDEL) Stock Moves -0.87%: What You Should Know

Quidel (QDEL) closed at $224.21 in the latest trading session, marking a -0.87% move from the prior day.

QIAGEN (QGEN) Announces COVID-19 Test Updates as Cases Rise

QIAGEN (QGEN) along with with Australia-based digital diagnostics company, Ellume develops QIAreach SARS-CoV-2 Antigen Test.

Top Ranked Growth Stocks to Buy for January 25th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 25th

Boston Scientific (BSX) Enhances Core Business With Buyout

Boston Scientific's (BSX) acquisition of Preventice solutions enables the former to expand rhythm management diagnostics portfolio and abilities.

Integra (IART) Acquires Acell, Focuses on Regenerative Space

The acquisition is expected to remain accretive to Integra's (IART) revenue growth and adjusted gross margins.

The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Becton, Dickinson and Co, Quidel and Hologic

The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Becton, Dickinson and Co, Quidel and Hologic

Globus Medical (GMED) US Spine Grows, Pricing Pressure Stays

Globus Medical's (GMED) recent product launches are seeing tremendous uptake.

Urmimala Biswas headshot

Federal, Private Tie-Ups Boost COVID-19 Testing Volume

The Department of Health and Human Services (HHS) promises over $22 billion of funding.

Insulet (PODD) Omnipod DASH Reaches Canada, Global Hold Widens

Insulet's (PODD) Omnipod DASH system provides 72 hours of continuous insulin therapy, simplifying lives with no more daily injection.

PerkinElmer (PKI) Receives FDA EUA for Asymptomatic Testing

PerkinElmer's (PKI) RT-PCR assay to test individuals without COVID-19 symptoms acts as prime factor in controlling the spread.

Nitish Marwah headshot

4 Momentum Stocks to Explore the Lucrative Driehaus Strategy

Investors who have the propensity to take a higher risk can think of investing in momentum stocks to boost their gains.